|Videos|February 16, 2016
- Head and Neck Cancers (Issue 4)
- Volume 3
- Issue 4
Dr. Ramona Dadu on Immunotherapies and Their Role in Thyroid Cancer
Author(s)Ramona Dadu, MD
Dadu says immunotherapies could afford patients with thyroid cancer an elongated progression free survival, potentially less toxicities, and most importantly an extensive overall survival benefit.
Ramona Dadu, MD, endocrinologist, MD Anderson Cancer Center, discusses the benefits of using immunotherapies in thyroid cancer and some of the potential drawbacks that coincide with the treatments. Dadu says immunotherapies could afford patients with thyroid cancer an elongated progression free survival, potentially less toxicities, and most importantly an extensive overall survival benefit.
Articles in this issue
almost 10 years ago
Immunotherapies Gaining Traction in Head and Neck Cancersalmost 10 years ago
Patient-Derived Xenografts Could Personalize Anaplastic Thyroid Cancer Carealmost 10 years ago
Dr. Sylvia Asa on Treating Different Types of Thyroid Canceralmost 10 years ago
Link Drawn Between Oral HPV and Risk of Head and Neck Cancersalmost 10 years ago
Nivolumab Could Change Head and Neck Cancer Treatment Paradigmalmost 10 years ago
Nivolumab Boosts OS in Phase III in SCCHN StudyRelated Content
Advertisement
